FDA Launches Pilot to Monitor Clinical Trial Data in Real Time, Says It Could Cut Trial Timelines by Up to 40 Percent
The FDA announced on April 28, 2026 a pilot with AI firm Paradigm Health covering trials run by Amgen and AstraZeneca, with the agency's chief AI officer estimating real-time data flows could shave 20 to 40 percent off trial timelines.